Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease. | Cell Stem Cell;31(2): 278-279, 2024 Feb 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.

Park, Sanghyun; Park, Chan Wook; Eom, Jang Hyeon; Jo, Mi-Young; Hur, Hye-Jin; Choi, Sung Kyoung; Lee, Jae Souk; Nam, Seung Taek; Jo, Ki-Sang; Oh, Young Woo; Lee, Jungil; Kim, Sieun; Kim, Do-Hun; Park, Chul-Yong; Kim, Su Jin; Lee, Ho-Young; Cho, Myung Soo; Kim, Dae-Sung; Kim, Dong-Wook.

Cell Stem Cell ; 31(2): 278-279, 2024 Feb 01.

Article in En | MEDLINE | ID: mdl-38306996

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Stem Cell Year: 2024 Document type: Article Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Stem Cell Year: 2024 Document type: Article Country of publication: Estados Unidos